Showing results (91-100 of 97) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
BMC Cancer|March 18, 2025
Telpegfilgrastim for chemotherapy-induced neutropenia in patients with non-small cell lung cancer: a multicentre, randomized, phase 3 studyYuankai Shi, Xinshuai Wang, Zhidong Pei, et al.Cancer Pathogenesis and Therapy|February 8, 2024
Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005-2018)Yuankai Shi, Haizhu Chen, Yan Qin, et al.Cancer Immunology, Immunotherapy : CII|November 24, 2021
Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapyQiaoyun Tan, Liyuan Dai, Yanrong Wang, et al.Experimental Hematology & Oncology|June 26, 2026
Safety, efficacy, and pharmacokinetics of eratrectinib (VC004) in solid tumors with NTRK fusions: phase 1 results from a phase 1/2 studyShengyu Zhou, Changgong Zhang, Guowen Wang, et al.Theranostics|June 3, 2020
Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patientsQiaoyun Tan, Dan Wang, Jianliang Yang, et al.Therapeutics and Clinical Risk Management|January 14, 2021
Clinical Features for Severely and Critically Ill Patients with COVID-19 in Shandong: A Retrospective Cohort StudyShengyu Zhou, Jiawei Xu, Wenqing Sun, et al.Journal of Hematology & Oncology|January 13, 2021
Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)Yuankai Shi, Jianqiu Wu, Zhen Wang, et al.Pageof 10